Peer Review History

Original SubmissionSeptember 4, 2023
Decision Letter - Ricardo de Mattos Russo Rafael, Editor

PONE-D-23-27170Interpersonal discrimination and depressive symptoms among older Black and African American adultsPLOS ONE

Dear Dr. Arnold,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This manuscript represents a significant contribution to both the academic realm and healthcare services by aiming to determine the relationship between various forms of interpersonal racial/ethnic discrimination and the severity of depressive symptoms. Overall, the work is well-conducted. However, a lack of crucial details that would ensure the robustness of the research has been noted, as highlighted by the reviewers. It is imperative that the suggestions and critiques detailed by them are considered and incorporated, aiming to enhance and enrich the study. Such a process will not only elevate the manuscript's quality but also broaden its impact and relevance in the field of study.

Please submit your revised manuscript by Mar 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ricardo de Mattos Russo Rafael, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Thank you for stating the following financial disclosure: 

   "This work was supported by the University of Michigan Depression Center (depressioncenter.org/), Strategic Translational Research Award to TDA. TDA was supported by the National Institute of Mental Health [grant number T32 MH073553-11] (nimh.nih.gov). CAP was supported by the National Institute on Aging [grant number K01AG059829] (nia.nih.gov). DTM was supported by the National Institute on Drug Abuse [grant number R01DA045705] (nida.nih.gov). This study was also supported by the National Institutes of Health [grant number P30 AG015281] (nih.gov), UMHealthResearch.org supported by the National Center for Advancing Translational Sciences [grant number UL1TR002240] (ncats.nih.gov), and the Michigan Center for Urban African American Aging Research (https://mcuaaar.org/)." 

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In the online submission form, you indicated that "Data is not publicly available due to the study being a pilot. However, data are available upon request."

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title: "Interpersonal Discrimination and Depressive Symptoms among Older Black and African American Adults"

The article aims to investigate the association between recent experiences of discrimination and the presentation and severity of depressive symptoms among a sample of older Black and African American adults in the United States. The objectives include determining whether various forms of interpersonal racial/ethnic discrimination are linked to the severity of depressive symptoms, as well as establishing whether vigilant coping with discrimination is associated with depressive symptom severity in this demographic.

The introduction is proficient in establishing conceptual foundations essential for the discourse and provides a solid basis for the subsequent analyses. The methodology employed is consistent with the study's purpose and executed competently, yielding highly significant findings for the study of racism and its influence on psychological distress. The results and analyses are of great value to the academic field, offering unique and underexplored contributions compared to other studies on this topic.

Particularly noteworthy are the associations identified between vigilance to discrimination and symptom severity. These reveal a positive correlation between vigilant coping and depression symptoms, indicating that a higher level of vigilant coping is linked to more severe affective symptoms of depression, though not with somatic symptom severity. This specific point opens up extensive possibilities for future studies, including those addressing diagnostic and nosographic issues within psychiatry, which must incorporate the production of psychological distress in relation to structural racism into their analytical scope.

This study makes substantial contributions to the field and receives a favorable recommendation for publication.

Reviewer #2: The manuscript approaches a highly important subject although many adjustments are needed. The manuscript aimed to determine whether different forms of interpersonal racial/ethnic discrimination were associated with depressive symptom severity, and determine whether vigilant coping with discrimination was associated with depressive symptom severity among older Black and African American adults. It addresses pertinent issues that could enhance our understanding of interpersonal racial/ethnic discrimination effects. However, it will be necessary to improve important aspects such as format, concepts, methods, results, and references.

Comments

1 - First of all it's important the paper follows the Plos One Submission Guidelines (Especially Reference style, Headings, Page and line numbers).

2 - Introduction - For greater clarity, it would be interesting to eliminate the subsections.

3 - Methods / Participants - “Participants were adults aged 50 and older who identified as Black or African American and who reported they had either used alcohol, cannabis, or prescription opioids or sedative tranquilizers at least once in the past month”. - Why were people selected who reported they had either used alcohol, cannabis, prescription opioids, or sedative tranquilizers at least once in the past month? It would be great to specify.

4 - Methods / Measures / Vigilant coping - Are there other recent studies that used the Heightened Vigilance Scale (HSV)?

5 - Methods / Measures / Covariates - Other covariates were tested in the model? Income? Marital Status? Employment Status?

6 - Methods / Analytic strategy - It would be important to specify the model’s adjustments, residual deviance, and which function was used.

7 - Results - It would be highly important to present results minutely. Please, present the crude and adjusted model. Describing the power of the associations found, not only the p-value.

8 - Conclusions - It would be great to present the conclusions in only one section.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tiago Braga do Espírito Santo

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

1. Thank you for responding to the earlier critiques. However, there is still some clarifications that would strengthen this paper. The abstract sill includes language that is overly general (e.g., “little is known about patterns of substance use and associated factors among patients with OUD”). Please revise to more accurately represent limitations in this domain, e.g., “But there is still more to learn about how patterns of substance misuse and associated factors among OUD patients vary by gender.”

Thank you for the clarification in feedback. We have removed the generic language in the Background section of the abstract to now read: “There is also still more to learn regarding how factors associated with continued and concurrent use might differ for men and women in methadone maintenance treatment (MMT).”

2. In the Conclusion section of the Abstract indicate why the study results are important.

We thank you for this feedback and have added more detail about why the study results are of importance.

3. There are two sets of Tables and Figures in the submitted manuscript. Please make sure that only one set is included in the next submission.

We appreciate you pointing out this mistake and have made sure that tables were not submitted twice in this revision.

4. Please add the word patients to the title, e.g., "Gender Differences in Patterns and Correlates of Continued Substance Use among Patients in Methadone Maintenance Treatment"

We appreciate the suggestion and have added “Among Patients” to the title to better reflect the topic.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Ricardo de Mattos Russo Rafael, Editor

Interpersonal discrimination and depressive symptoms among older Black and African American adults

PONE-D-23-27170R1

Dear Dr. Arnold,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ricardo de Mattos Russo Rafael, Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The present study presents scientific quality and academic relevance for publication.

The authors responded competently to the comments raised by the reviewers.

the data are collected and the analyzes were carried out competently and carefully.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tiago Braga do Espírito Santo

**********

Formally Accepted
Acceptance Letter - Ricardo de Mattos Russo Rafael, Editor

PONE-D-23-27170R1

PLOS ONE

Dear Dr. Arnold,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ricardo de Mattos Russo Rafael

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .